My initial reaction when unboxing my Arc’teryx Vertex Alpine GTX approach shoes was to reach for my best sunglasses, because the ‘Euphoria & Graphite’ color scheme of my test pair is bright enough to ...
Vertex Pharmaceuticals is anchored by cystic fibrosis as launches lag, JOURNAVX and CASGEVY add little revenue, and growth is ...
Zacks Investment Research on MSN
Vertex Pharmaceuticals (VRTX) stock sinks as market gains: Here's why
Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $438.92, moving -2.36% from the previous trading session.
William Blair analyst Jake Roberge has maintained their bullish stance on VERX stock, giving a Buy rating today. Jake Roberge has given his Buy rating due to a combination of factors including ...
Zacks Investment Research on MSN
Vertex Pharmaceuticals Incorporated (VRTX) is attracting investor attention: Here is what you should know
Vertex Pharmaceuticals (VRTX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...
Bradley Sills, an analyst from Bank of America Securities, reiterated the Hold rating on Vertex (VERX – Research Report). The associated price target was raised to $40.00. Bradley Sills has given his ...
Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Vertex Minerals Ltd. announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback